Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Retained Earnings (2020 - 2026)

Biomea Fusion (BMEA) posted Retained Earnings of -$461.5 million for Q1 2026, down 2.76% sequentially from -$449.0 million in Q4 2025, and down 10.8% YoY from -$517.3 million in Q1 2025.

Biomea Fusion (BMEA) Retained Earnings (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Retained Earnings for 7 years, with the latest figure at -$461.5 million in Q1 2026.

  • Quarterly Retained Earnings fell 10.8% year-over-year to -$461.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$461.5 million (down 10.8% YoY) and the FY2025 annual result came in at -$449.0 million, down 15.96% from the prior year.
  • Retained Earnings fell to -$461.5 million in Q1 2026 per BMEA's latest filing, from -$449.0 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $423.2 million in Q1 2024 and troughed at -$461.5 million in Q1 2026.
  • A 5-year average of -$187.0 million and a median of -$213.9 million in 2023 frame the typical range for Retained Earnings.
  • The widest YoY moves for Retained Earnings: up 41805900.0% in 2023, down 1091147.06% in 2023.
  • Over 5 years, Retained Earnings stood at -$1000.0 in 2022, then jumped by 41805900.0% to $418.1 million in 2023, then tumbled by 192.63% to -$387.3 million in 2024, then fell by 15.96% to -$449.0 million in 2025, then fell by 2.76% to -$461.5 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$461.5 million, -$449.0 million, and -$453.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.10 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.05 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -6.33 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 20.91 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.57 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 4.38 Bn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 481.92 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 481.92 Mn
Mar 31, 2026 -461.46 Mn
Dec 31, 2025 -449.05 Mn
Sep 30, 2025 -453.66 Mn
Jun 30, 2025 -437.30 Mn
Mar 31, 2025 -416.50 Mn
Dec 31, 2024 -387.25 Mn
Sep 30, 2024 -357.90 Mn
Jun 30, 2024 -325.16 Mn
Mar 31, 2024 423.20 Mn
Dec 31, 2023 418.06 Mn
Sep 30, 2023 -213.90 Mn
Jun 30, 2023 -185.51 Mn
Mar 31, 2023 -160.60 Mn
Dec 31, 2022 -1,000.00
Sep 30, 2022 -106.26 Mn
Jun 30, 2022 -17,000.00
Mar 31, 2022 -66.11 Mn
Dec 31, 2021 -10,000.00
Sep 30, 2021 226.36 Mn